EDITORIAL
Published on 08 May 2019
Editorial: Management of Immune-Related Adverse Events for Patients Undergoing Treatment With Checkpoint Inhibitors
doi 10.3389/fonc.2019.00365
- 1,951 views
- 3 citations
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Management of Immune-Related Adverse Events for Patients Undergoing Treatment with Checkpoint Inhibitors
Management of Immune-Related Adverse Events for Patients Undergoing Treatment with Checkpoint Inhibitors
7,264
Total downloads
29k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
SYSTEMATIC REVIEW
Published on 11 Dec 2018
The Relative Risk and Incidence of Immune Checkpoint Inhibitors Related Pneumonitis in Patients With Advanced Cancer: A Meta-Analysis
doi 10.3389/fphar.2018.01430
- 7,343 views
- 105 citations
CASE REPORT
Published on 25 Sep 2018
Management of Persistent Pruritus and Lichenoid Reaction Secondary to Nivolumab With Narrowband Ultraviolet B Phototherapy
doi 10.3389/fonc.2018.00405
- 7,567 views
- 16 citations
REVIEW
Published on 22 Mar 2018
Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice
doi 10.3389/fonc.2018.00080
- 4,472 views
- 39 citations
REVIEW
Published on 15 Nov 2017
Checkpoint Blockade Toxicity and Immune Homeostasis in the Gastrointestinal Tract
doi 10.3389/fimmu.2017.01547
- 8,386 views
- 135 citations
Published in
Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 29kTopic views
- 19kArticle views
- 7,264Article downloads